[{"address1": "427 Park Street", "city": "Charlottesville", "state": "VA", "zip": "22902", "country": "United States", "phone": "434 297 1000", "website": "https://acumenpharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.", "fullTimeEmployees": 51, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel J. O'Connell M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 1043294, "exercisedValue": 0, "unexercisedValue": 3599341}, {"maxAge": 1, "name": "Mr. Matt  Zuga", "title": "CFO & Chief Business Officer", "fiscalYear": 2023, "totalPay": 702601, "exercisedValue": 0, "unexercisedValue": 884506}, {"maxAge": 1, "name": "Mr. Derek M. Meisner Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 752945, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Doherty Ph.D.", "age": 56, "title": "President & Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Grant A. Krafft Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "totalPay": 42000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Caleb E. Finch Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William L. Klein Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Barton M.S.", "age": 66, "title": "Chief Operating Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 223680, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Carranza", "title": "Vice President, Finance & Accounting and Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alex  Braun M.B.A.", "title": "VP & Head of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.38, "open": 1.4, "dayLow": 1.365, "dayHigh": 1.43, "regularMarketPreviousClose": 1.38, "regularMarketOpen": 1.4, "regularMarketDayLow": 1.365, "regularMarketDayHigh": 1.43, "payoutRatio": 0.0, "beta": -0.006, "forwardPE": -0.90849674, "volume": 400333, "regularMarketVolume": 397611, "averageVolume": 321569, "averageVolume10days": 232930, "averageDailyVolume10Day": 232930, "bid": 1.37, "ask": 1.41, "bidSize": 2, "askSize": 2, "marketCap": 83510920, "fiftyTwoWeekLow": 1.282, "fiftyTwoWeekHigh": 5.09, "fiftyDayAverage": 1.7012, "twoHundredDayAverage": 2.480625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -87444904, "profitMargins": 0.0, "floatShares": 32299489, "sharesOutstanding": 60079800, "sharesShort": 1840069, "sharesShortPriorMonth": 1555225, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0306, "heldPercentInsiders": 0.11236, "heldPercentInstitutions": 0.76565003, "shortRatio": 5.78, "shortPercentOfFloat": 0.041100003, "impliedSharesOutstanding": 60079800, "bookValue": 3.615, "priceToBook": 0.384509, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -81672000, "trailingEps": -1.38, "forwardEps": -1.53, "enterpriseToEbitda": 0.942, "52WeekChange": -0.6123595, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 1.39, "targetHighPrice": 15.0, "targetLowPrice": 6.0, "targetMeanPrice": 10.8, "targetMedianPrice": 11.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 200343008, "totalCashPerShare": 3.335, "ebitda": -92838000, "totalDebt": 29988000, "quickRatio": 10.076, "currentRatio": 10.426, "debtToEquity": 13.807, "returnOnAssets": -0.20987, "returnOnEquity": -0.32834998, "grossProfits": -43564000, "freeCashflow": -41690752, "operatingCashflow": -67314000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ABOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Acumen Pharmaceuticals, Inc.", "marketState": "POST", "corporateActions": [], "postMarketTime": 1740171903, "regularMarketTime": 1740171602, "exchange": "NMS", "messageBoardId": "finmb_8539521", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.724637, "regularMarketPrice": 1.39, "postMarketChange": 0.0, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.365 - 1.43", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 321569, "fiftyTwoWeekLowChange": 0.10800004, "fiftyTwoWeekLowChangePercent": 0.0842434, "fiftyTwoWeekRange": "1.282 - 5.09", "fiftyTwoWeekHighChange": -3.7000003, "fiftyTwoWeekHighChangePercent": -0.72691554, "fiftyTwoWeekChangePercent": -61.235954, "earningsTimestampStart": 1742819400, "earningsTimestampEnd": 1743165000, "earningsCallTimestampStart": 1731416400, "earningsCallTimestampEnd": 1731416400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.38, "epsForward": -1.53, "epsCurrentYear": -1.32231, "priceEpsCurrentYear": -1.0511907, "fiftyDayAverageChange": -0.31120002, "fiftyDayAverageChangePercent": -0.18292971, "twoHundredDayAverageChange": -1.0906249, "twoHundredDayAverageChangePercent": -0.43965733, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-01", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "longName": "Acumen Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1625146200000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.39, "displayName": "Acumen Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]